SCM
ESRX

Smead Capital Management’s Express Scripts Holding Company ESRX Stock Holding History

Smead Capital Management’s Portfolio ESRX Stock Details ESRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-919,209
Closed -$60.6M – 29
2017
Q1 		$60.6M Buy
919,209
+132,361
+17% +$9.11M 3.05% 19
2016
Q4 		$54.1M Buy
786,848
+357,866
+83% +$25.6M 2.75% 19
2016
Q3 		$30.3M Buy
+428,982
New +$32.1M 1.44% 24

Other funds holding ESRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Smead Capital Management's ESRX Position: Q2 2017 in Review

Smead Capital Management sold out of Express Scripts Holding Company (ESRX) in Q2 2017, closing a stake of 919,209 shares — an estimated $60.6M sold.

Smead Capital Management first reported a position in ESRX in Q3 2016 and held it in 3 quarters. The position peaked at $60.6M in Q1 2017. 1,046 funds tracked by Wall St. Rank hold ESRX as of Q2 2017.

  • Smead Capital Management reported no remaining Express Scripts Holding Company position as of Q2 2017 after selling out during the quarter.
  • Smead Capital Management sold 919,209 Express Scripts Holding Company shares in Q2 2017, an estimated $60.6M.
  • Smead Capital Management first reported a position in Express Scripts Holding Company in Q3 2016 and held it in 3 quarters.
  • Smead Capital Management's Express Scripts Holding Company position peaked at $60.6M in Q1 2017.
  • 1,046 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q2 2017.

Based on Smead Capital Management's 13F filing for Q2 2017, filed 27 Jul 2017.